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Ⅰ．Introduction
 Osteonecrosis of the femoral head impairs quality of 
life in young and active individuals［1］. Corticosteroid-
associated osteonecrosis in systemic lupus erythemato-
sus （SLE） was first reported by Dubois and Cozen in 
1960［2］. The pathogenesis of osteonecrosis has been 
unclear to date, but corticosteroid use has been widely 
accepted to be influential in the development of osteo-
necrosis［3］. Corticosteroid therapy is an ideal way to 
reveal the pathogenesis of osteonecrosis because it is 
straightforward to evaluate the precise dosage and dura-
tion of corticosteroid therapy in patients with osteone-
crosis.
 Magnetic Resonance Imaging （MRI） was first 
utilized for the diagnosis of osteonecrosis in 1983
［4,5］and is now the gold standard for initial diagnosis 
of osteonecrosis because MRI is more sensitive in 
demarcating normal bone from the necrotic lesion much 
earlier than simple X-rays. The purpose of this study 
is to review the improvements that the development 
of MRI technology has made in the investigation into 
the pathogenesis of osteonecrosis of the femoral head 
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SUMMARY
Magnetic Resonance Imaging （MRI） was first utilized for the diagnosis of osteonecrosis in 1983. 
The purpose of this current study is to review the past 30 years of achievement using new developments 
in MRI technology for investigation into the pathogenesis of osteonecrosis of the femoral head 
associated with corticosteroid therapy. From 1983 to 2013, 165 MRI studies were reported: 25 articles 
in 1983-1993, 55 in 1994-2003, and 85 in 2004-2013. Forty-nine articles were reported from Japan, 44 
from the United States, and 18 from China. Eighty-two studies were retrospective, 49 were prospective, 
20 were case reports, two were genotyping studies, and 10 used animal models. MRI is a promising tool 
for monitoring osteonecrosis and analyzing the pathogenesis in both clinical and experimental studies. 
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associated with corticosteroid therapy 30 years after the 
first clinical application of this imaging methodology.
Ⅱ．Materials and Methods
 A systematic review was performed using PubMed 
（US National Library of Medicine, National Institutes 
of Health） on January 1st 2014. Inclusion criteria 
were original articles written in English and published 
between 1983 and 2013 related to corticosteroid-
associated osteonecrosis of the femoral head using MRI. 
Exclusion criteria were review articles or other unrelated 
papers. Filters for key words were “osteonecrosis” AND 
（“femoral head” OR “hip”） AND “MRI” AND （“steroid” 
OR “steroids” OR “corticosteroid” OR “corticosteroids”） 
AND “English［lang］”. Articles during this 30 year 
period were divided into three groups by 10 year 
increments: 1983-1993 ,  1994-2003 ,  and 2004-
2013. The number of articles, country of contribution, 
type of study, and impact factor in 2013 （Journal of 
Citation Reports, Thomson Reuters, New York） were 
analyzed. Furthermore, MRI-based etiology, diagnosis, 
classification, prognosis, and treatment outcome were 
reviewed. 
Ⅲ．Results
 We identified 203 articles via PubMed published 
between 1983-2013 of which 165 met the inclusion 
criteria. The number of MRI studies increased each 
decade: 25 articles in 1983-1993, 55 in 1994-2003, 
and 85 in 2004-2013 （Table 1）. Forty-nine articles 
Table 1　MRI articles of osteonecrosis of the femoral head by decade
1983-1993 1994-2003 2004-2013 Total
Number of articles 25 55 85 165
Number of countries 4 13 21 25
Ranking of achievements 
（articles）
USA （22）
France （1）
Japan （1）
UK （1）
Japan （22）
USA （14）
France （3）
Germany （3）
Korea （3）
Greece （2）
UK （2）
Canada （1）
Denmark （1）
Italy （1）
Netherlands （1）
Switzerland （1）
Taiwan （1）
Japan （26）
China （18）
Turkey （6）
USA （8）
Thailand （3）
Austria （2）
Canada （2）
France （2）
Greece （2）
India （2）
Italy （2）
Taiwan （2）
UK （2）
Argentina （1）
Australia （1）
Belgium （1）
Brazil （1）
Ireland （1）
Netherland （1）
Spain （1）
Tunisia （1）
Japan （49）
USA （44）
China （18）
France （6）
Turkey （6）
UK （5）
Greece （4）
Canada （3）
Germany （3）
Italy （3）
Korea （3）
Taiwan （3）
Thailand （3）
Austria （2）
India （2）
Netherland （2）
Argentina （1）
Australia （1）
Bergium （1）
Brazil （1）
Denmark （1）
Ireland （1）
Spain （1）
Switzerland （1）
Tunisia （1）
Type of study
Clinical 23
Animal 2
Clinical 54
Genotyping 1
Clinical 74
Genotyping 1
Animal 10
Clinical 151
Genotyping 2
Animal 12
Case report 1 5 14 20
Prospective study 2 18 29 49
Retrospective study 20 31 31 82
Mean impact factor 4.129 3.465 2.437 3.040
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were reported from Japan, 44 from the United States, 
and 18 from China. In Japan, 16 of 49 articles （33%） 
were studied in Chiba University. Reports were received 
from four countries in 1983-1993, 13 countries in 1994-
2003, and 21 countries in 2004-2013. However, over 30 
years, 67% of the articles about osteonecrosis generated 
were from Japan, the U.S. or China. In the last decade, 
Japan and China in particular increased the number of 
their publications in this area. Clinical studies comprised 
151 articles: 82 were retrospective studies, 49 were 
prospective studies, and 20 were case reports. MRI 
prospective studies increased over the three decades. In 
the last decade, experimental studies using MRI were 
identified in two articles about genotyping and in 10 
articles using animal models. The mean impact factor 
in 2013 of the journals that published these articles was 
3.04 （range: 0 to 17.879）.
Ⅳ．Discussion
Achievements in the first decade （1983-1993） era of 
diagnosis
 The phenomenon of nuclear magnetic resonance 
was discovered in 1946［6,7］, and it was demonstrated 
as the basis of an imaging technique in 1973［8］. The 
appearance of MRI made it possible by 1983 to visualize 
lesions of the musculoskeletal system［4,5］. MRI has 
rapidly become the gold standard for early diagnosis of 
osteonecrosis because of its compatibility with histology
［9］. MRI is a more sensitive and reliable technique 
than conventional X-rays, computed tomography or 
radionuclide bone scanning, with 85-100% sensitivity 
and 98% specificity for the early diagnosis of 
osteonecrosis of the femoral head［10-12］. Immediately 
after ischemia, the ischemic area of bone marrow is not 
visible by MRI. However, the healing and growth of 
the fibrous reactive tissue into the necrotic area replaces 
the dead marrow, and can be identified with MRI by 
its different characteristics. A low-signal intensity band 
represents the repair tissue interface surrounding a 
high-signal-intensity necrotic marrow segment. MRI 
and single-photon emission computed tomography 
can detect osteonecrosis within 4 months after renal 
transplantation［13］, and can be used to monitor the 
course of the affected hip in patients with osteonecrosis
［14］. Characteristic abnormalities of osteonecrosis on 
MRI are described by patterns that are homogeneous, 
inhomogeneous, ring, or band patterns［15］. The early 
conversion from hematopoietic marrow to fatty marrow 
in patients with osteonecrosis of the femoral head may 
reflect decreased vascularity of the proximal femur［16］. 
Cova et al［17］. developed a dog model to evaluate bone 
marrow perfusion using gadolinium-enhanced dynamic 
MRI and probed the peak percentage of enhancement 
（i.e. blood supply） using blood-borne microspheres. 
In another dog model, dynamic contrast-enhanced 
MR imaging proved significantly more sensitive than 
spin-echo and short tau inversion recovery imaging 
in the earlier detection of acute avascular necrosis
［18］. Normal marrow was characterized by rapid 
enhancement, although the marrow of the ischemic 
femoral head with avascular marrow showed persistent 
lack of enhancement. A junctional zone, characterized 
by rapid contrast enhancement in excess of 120% 
without early washout, was identified at the interface 
between normal and avascular marrow. Kopecky et al
［19］. reported the first MRI prospective study for 24 
months after renal transplantation in 104 recipients, 
with 12% incidence of osteonecrosis of the femoral 
head. Of 25 affected hips, seven hips became painful 
but 18 hips remained asymptomatic. All MR lesion 
sizes in the symptomatic hips were larger than those in 
the asymptomatic hips. MR lesions regressed in size 
in seven hips and disappeared in six hips, showing 
spontaneous improvement. 
Achievements in the second decade （1994-2003） era 
of epidemiology
 Corticosteroid-associated osteonecrosis is multifocal, 
with 66% of the MRI-identified lesions in the hip, 51% 
in the knee, 16% in the ankle, and 16% in the shoulder
［20］. Bilateral MRI screening of the hip and knee is an 
effective method to diagnose osteonecrosis in patients 
with high dose corticosteroid therapy （more than 30mg/
day）. The incidence of osteonecrosis of the femoral 
head has been reported in prospective observational 
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MRI studies as 32% in various autoimmune-related 
disorders［21］, 44% in SLE patients［22］, and 23% in 
renal allograft recipients［23］. Moreover, osteonecrotic 
lesions were identified 3-4 months after initiation 
of corticosteroid therapy in those studies［21-23］. 
The incidence of osteonecrosis was much higher 
and the development of osteonecrosis much earlier 
than expected based on conventional X-rays because 
MRI can detect asymptomatic and non-collapsed 
osteonecrosis. Therefore, an ischemic event that causes 
osteonecrosis seems to occur within 3-4 months after 
corticosteroid administration, considering the time lag 
of the reparative reaction to the dead bone. The initial 
MR sign of asymptomatic osteonecrosis in the early 
stage is a band-like pattern; bone marrow edema is a 
sign of collapse with advanced stage osteonecrosis that 
occurs with pain［23,24］. Bone marrow edema is easily 
detected with fat suppression images［25］, but this 
makes it difficult to distinguish the viable area from the 
necrotic area. Gadolinium-enhanced MRI can demarcate 
the boundary of the reactive zone［26］.
 Lesion size and lesion location are both strongly 
correlated with risk of collapse in osteonecrosis［27］. 
The survival rate at 32 months was 100% for the small 
osteonecrotic lesions within one-third of the weight-
bearing area of the acetabulum in coronal MRI （Grade 
a）［27］. The survival rate was 86% for the moderate 
lesions between one-third and two-thirds of the weight-
bearing area （Grade b）, and 29% for the large lesions, 
which encompassed more than two-thirds of the weight-
bearing area （Grade c）［27］. Kubo et al.［23］found 
same evidence that a large lesion （Grade c） became 
symptomatic 7-14 months after renal transplantation 
and then progressed to collapse. Based on these facts, 
the Japanese Ministry of Health, Labor and Welfare 
（JMHLW） established a classification using the 
boundary of a necrotic lesion as a low-intensity band 
on the central coronal section of the femoral head on 
T1-weighted images［28］. Lesions are classified into 
the following four types: type A-lesion occupies the 
medial one-third or less of the weight-bearing area; type 
B-lesion occupies the medial two-thirds or less of the 
weight-bearing area; type C1-lesion occupies more than 
the medial two-thirds of the weight-bearing area but 
does not extend laterally to the acetabular edge; and type 
C2-lesion extends laterally to the acetabular edge. The 
MRI-based JMHLW type classification showed excellent 
inter-observer and intra-observer reliabilities （weighted 
kappa of 0.709-0.724 and 0.780-0.800, respectively）
［29］. Other methods have been used to attempt to 
quantify the extent of osteonecrosis. Lafforgue et al
［30］. proposed three quantitative parameters: the angle 
filled by the lesion （alpha）; the percentage of weight-
bearing femoral cortex that was osteonecrotic; and 
the percentage of osteonecrotic femoral head surface. 
Steinberg et al［31,32］. calculated the percentage of 
lesion size by estimating the average area of abnormality 
on serial MR images, classifying them into three groups 
based on lesion size: Group A, less than 15% of femoral 
head involvement; Group B, 15% to 30%; and Group C, 
greater than 30%. Koo et al［33］. developed a formula 
from a combination of the arc of the necrotic portion in 
the mid-coronal image （A） and that in the mid-sagittal 
image （B）: （A/180）×（B/180）×100. Nishii et al［34］. 
performed a three-dimensional quantification of lesion 
volume as well as latitude and longitude of the center of 
gravity of the lesion within the femoral head.
 Aggressive treatment such as core-decompression 
is undertaken for asymptomatic osteonecrosis
［14-16,30-33］,  presumably because spontaneous 
healing or regression of the lesion has been believed 
to be extremely rare［35］. However, Sakamoto et al
［21］. observed spontaneous reduction of lesion size 
within one year after corticosteroid therapy in 45% 
of osteonecrosis cases, although there was no further 
change with a longer follow-up of 31 months. Oinuma 
et al［22］. reported that no new lesions were detectable 
from 6 months to 12 months after corticosteroid therapy 
in SLE patients. Kubo et al. also reported that no new 
abnormal findings on MRI were detected between one 
year and 4.3 years in renal allograft recipients［23］. 
Osteonecrosis after renal transplantation has decreased 
because the development of novel immunosuppressant 
agents has decreased the necessity for corticosteroid 
treatment［36］. Pritchett et al［37］. suggested that 
statins have a preventive effect against developing 
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in those with other autoimmune diseases （37% versus 
21%）［40］. SLE patients have a significantly higher risk 
of osteonecrosis than non-SLE patients （Odds ratio＝
2.6）, and male patients have a significantly higher risk 
than female patients （Odds ratio＝1.6）. Alcohol intake 
is also a risk factor for developing osteonecrosis, but the 
pathogenesis seems to be slightly different from that of 
corticosteroid-induced osteonecrosis, and is specific to 
the femoral head. The incidence of alcohol-associated 
osteonecrosis of the knee is lower than the incidence of 
steroid-associated osteonecrosis of the knee in patients 
with osteonecrosis of the femoral head［46］. Vande Berg 
et al［47］. proposed that baseline femoral neck status 
was a predictive factor for developing corticosteroid-
associated osteonecrosis of the femoral head because 
osteonecrosis was correlated with high marrow fat in the 
proximal femur before corticosteroid therapy, supporting 
the bone marrow conversion theory of Mitchel et al［16］.
 The natural history of osteonecrosis of the femoral 
head has been monitored longitudinally with MRI. 
The frequency of articular collapse was significantly 
higher in osteonecrosis of the femoral head than in 
osteonecrosis of the knee （38% versus 5%）［48］. After 
articular collapse, surgery was performed significantly 
more often for osteonecrosis of the femoral head than for 
osteonecrosis of the knee （63% versus 29%）［48］. On 
the other hand, spontaneous repair of osteonecrosis has 
been revealed by long-term observational MRI studies
［49-53］. Spontaneous repair of the lesion occurred in 
61% of SLE patients over 10 years of follow-up［49］. 
The lesion volume was reduced in 95% of patients 
with severe acute respiratory syndrome who developed 
osteonecrosis of the femoral head, but the remaining 
hips with relatively larger lesion volumes showed no 
apparent reductions over five years of follow-up［52］. 
The reduction in lesion size observed on MRI is a slow, 
discontinuous and time-dependent process. Factors 
favorable to resolution are early diagnosis, asymptomatic 
disease, and small lesion size［50］.
 Other novel imaging techniques also have 
been developed to assess changes associated with 
osteonecrosis. T2 mapping, a quantitative evaluation of 
cartilage matrix status including hydration and collagen 
osteonecrosis, observing that treatment reduced the 
incidence of osteonecrosis to only 1% in patients who 
received statin drugs during the entire time of steroid 
exposure. High-dose corticosteroid treatment causes 
hemostatic abnormality. Plasmin-α2-plasmin inhibitor 
complex was significantly higher in autoimmune disease 
patients with osteonecrosis than in those without［38］. 
The number of osteonecrotic joints was correlated with 
the plasmin inhibitor levels. Hypofibrinolysis conferred 
by the 4G/4G plasminogen activator inhibitor-1 gene 
variant is a major predisposing factor for osteonecrosis 
in renal transplant recipients［39］.
Achievements in the third decade （2004-2013） era of 
novel imaging techniques
 The pathogenesis of corticosteroid-associated 
osteonecrosis is still controversial, but the dosage of 
daily oral corticosteroids seems the most influential 
factor. A high dose of oral corticosteroids （＞40mg/
day） is a risk factor for development of osteonecrosis
［40］, partly because blood supply to the femoral 
head decreases in the early period after high-dose 
corticosteroid therapy. Blood supply can increase 
when the corticosteroid dose is reduced［41］. De novo 
osteonecrosis develops after increased corticosteroid 
use for SLE recurrence in patients who did not have 
osteonecrosis for at least ten years prior to the induction 
of corticosteroid use［42,43］. Other risk factors for 
osteonecrosis have been hypothesized, such as age, 
underlying disease, sex, and alcohol. Dynamic enhanced 
MRI reveals that blood supply to the femoral head is 
more abundant in children （especially at the growth 
plate） than in adults［41］. This characteristic seems to 
explain the lower incidence of osteonecrosis in children
［44,45］. Pediatric SLE patients showed a lower rate of 
osteonecrosis than adolescent and adult patients （6% 
versus 41%）［44］. In pediatric acute lymphoblastic 
leukemia, the median age at corticosteroid induction 
was 13.5 years for patients who developed osteonecrosis 
and was 4.7 years for those without osteonecrosis
［45］. Corticosteroid-associated osteonecrosis has 
been reported in various disorders, but the incidence of 
osteonecrosis in SLE patients is significantly higher than 
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in both clinical and experimental studies.
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